Abstract
P-113 Clinical consensus on first-line (1L) treatments for transplant-ineligible (TIE) patients with newly diagnosed multiple myeloma (NDMM): delphi panel of US hematologists and oncologists
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
